| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $1.0M | +3.7% | +67.0% |
| SG&A Expense | $751K | -20.7% | -56.7% |
| Operating Income | -$1.8M | +8.2% | +24.1% |
| Pre-tax Income | -$1.7M | +7.5% | +22.5% |
| Income Tax | $26K | +18.2% | — |
| Net Income | -$1.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $12.5M | +30.8% | — |
| Short-term Investments | $141K | — | — |
| Current Assets | $24.4M | -5.1% | — |
| Total Assets | $29.5M | -5.0% | — |
| Current Liabilities | $12.9M | +9.9% | — |
| Total Liabilities | $49.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$14.3M | — | — |
| Capital Expenditures | $50K | — | — |
| Investing Cash Flow | $15.9M | — | — |
| Financing Cash Flow | $3.0M | — | — |
| Free Cash Flow | -$14.3M | — | — |
| +27.8% |
| EPS (Basic) | -$0.04 | +0.0% | +20.0% |
| EPS (Diluted) | -$0.03 | +70.0% | — |
| +1.5% |
| — |
| Stockholders' Equity | -$31.8M | -5.2% | -188.5% |